Development
D
Hydreight Technologies Inc. NURS.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue 164.31% 209.03% 301.53% 340.34% 207.16%
Total Other Revenue -- -- -- -- --
Total Revenue 164.31% 209.03% 301.53% 340.34% 207.16%
Cost of Revenue 223.75% 274.82% 255.97% 424.68% 186.53%
Gross Profit 109.27% 144.69% 365.10% 234.58% 229.11%
SG&A Expenses 102.59% 113.67% 251.85% 187.93% 284.36%
Depreciation & Amortization -44.00% 75.36% -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 149.31% 174.19% 256.45% 268.86% 241.30%
Operating Income -78.34% -61.81% 627.94% -163.28% -619.53%
Income Before Tax -89.03% -74.43% 123.39% -1,836.83% -619.53%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -89.03% -74.43% 123.39% -1,754.00% -619.53%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -89.03% -74.43% 123.39% -1,754.00% -619.53%
EBIT -78.34% -61.81% 627.94% -163.28% -619.53%
EBITDA -85.21% -62.01% -- -- --
EPS Basic -- -- -- -- --
Normalized Basic EPS -- -- -- -- --
EPS Diluted -- -- -- -- --
Normalized Diluted EPS -- -- -- -- --
Average Basic Shares Outstanding -- -- -- -- --
Average Diluted Shares Outstanding -- -- -- -- --
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --